![Thomas Balzer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: - $ in data 31/08/2026
Thomas Balzer is currently Chief Medical Officer & SVP-Clinical Development at Lakewood-Amedex Biotherapeutics, Inc. since 2023.
Formerly, Dr. Balzer was Vice President at Bayer U.S.
LLC.
Education includes a doctorate from Freie Universität Berlin.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 30/07/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| LAKEWOOD-AMEDEX BIOTHERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 01/11/2022 |
| Società | Posizione | Fine |
|---|---|---|
Bayer U.S. LLC
 Bayer U.S. LLC Information Technology ServicesTechnology Services Provides information technology services | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 3 |
|---|---|
Freie Universität Berlin
 Freie Universität Berlin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Amedex Therapeutics, Inc.
 Amedex Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company focused on discovery and development of novel antimicrobial therapeutics | Health Technology |
Bayer U.S. LLC
Bayer U.S. LLC Information Technology ServicesTechnology Services Provides information technology services | Technology Services |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
